Efficacy and Safety of the Nucleoside Analog GS-441524 for Treatment of Cats with Naturally Occurring Feline Infectious Peritonitis

Overview

Journal J Feline Med Surg

Specialty Veterinary Medicine

Date 2019 Feb 14

PMID 30755068

Citations 122

Authors

Niels C Pedersen

Michel Perron

Michael Bannasch

Elizabeth Montgomery

Eisuke Murakami

Molly Liepnieks

Hongwei Liu

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study was to determine the safety and efficacy of the nucleoside analog GS-441524 for cats suffering from various forms of naturally acquired feline infectious peritonitis (FIP).

Methods: Cats ranged from 3.4-73 months of age (mean 13.6 months); 26 had effusive or dry-to-effusive FIP and five had non-effusive disease. Cats with severe neurological and ocular FIP were not recruited. The group was started on GS-441524 at a dosage of 2.0 mg/kg SC q24h for at least 12 weeks and increased when indicated to 4.0 mg/kg SC q24h.

Results: Four of the 31 cats that presented with severe disease died or were euthanized within 2-5 days and a fifth cat after 26 days. The 26 remaining cats completed the planned 12 weeks or more of treatment. Eighteen of these 26 cats remain healthy at the time of publication (OnlineFirst, February 2019) after one round of treatment, while eight others suffered disease relapses within 3-84 days. Six of the relapses were non-neurological and two neurological. Three of the eight relapsing cats were treated again at the same dosage, while five cats had the dosage increased from 2.0 to 4.0 mg/kg q24h. The five cats treated a second time at the higher dosage, including one with neurological disease, responded well and also remain healthy at the time of publication. However, one of the three cats re-treated at the original lower dosage relapsed with neurological disease and was euthanized, while the two remaining cats responded favorably but relapsed a second time. These two cats were successfully treated a third time at the higher dosage, producing 25 long-time survivors. One of the 25 successfully treated cats was subsequently euthanized due to presumably unrelated heart disease, while 24 remain healthy.

Conclusions And Relevance: GS-441524 was shown to be a safe and effective treatment for FIP. The optimum dosage was found to be 4.0 mg/kg SC q24h for at least 12 weeks.

Citing Articles

Feline Coronavirus in Northern Vietnam: Genetic Detection and Characterization Reveal Predominance of Type I Viruses.

Dong H, Rapichai W, Rattanasrisomporn A, Rattanasrisomporn J Viruses. 2025; 17(2).

PMID: 40006943 PMC: 11860192. DOI: 10.3390/v17020188.

The Nucleoside Analog GS-441524 Effectively Attenuates the In Vitro Replication of Multiple Lineages of Circulating Canine Distemper Viruses Isolated from Wild North American Carnivores.

Oliver-Guimera A, Murphy B, Keel M Viruses. 2025; 17(2).

PMID: 40006905 PMC: 11861726. DOI: 10.3390/v17020150.

Predictive factors associated with short-term mortality in cats with feline infectious peritonitis treated with remdesivir or GS-441524 or both.

Goto S, Kamiyoshi T, Iwasaki R J Vet Intern Med. 2024; 39(1):e17249.

PMID: 39600237 PMC: 11638120. DOI: 10.1111/jvim.17249.

Protoporphyrin IX-Dependent Antiviral Effects of 5-Aminolevulinic Acid against Feline Coronavirus Type II.

Doki T, Shimada J, Tokunaga M, To K, Orino K, Takano T Viruses. 2024; 16(10).

PMID: 39459928 PMC: 11512371. DOI: 10.3390/v16101595.

Open label clinical trial of orally administered molnupiravir as a first-line treatment for naturally occurring effusive feline infectious peritonitis.

Reagan K, Brostoff T, Pires J, Rose A, Castillo D, Murphy B J Vet Intern Med. 2024; 38(6):3087-3094.

PMID: 39327677 PMC: 11586577. DOI: 10.1111/jvim.17187.

References

Rohrbach B, Legendre A, Baldwin C, Lein D, Reed W, Wilson R . Epidemiology of feline infectious peritonitis among cats examined at veterinary medical teaching hospitals. J Am Vet Med Assoc. 2001; 218(7):1111-5. DOI: 10.2460/javma.2001.218.1111. View

Kim Y, Liu H, Galasiti Kankanamalage A, Weerasekara S, Hua D, Groutas W . Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor. PLoS Pathog. 2016; 12(3):e1005531. PMC: 4814111. DOI: 10.1371/journal.ppat.1005531. View

Pesteanu-Somogyi L, Radzai C, Pressler B . Prevalence of feline infectious peritonitis in specific cat breeds. J Feline Med Surg. 2005; 8(1):1-5. PMC: 7128820. DOI: 10.1016/j.jfms.2005.04.003. View

De Clercq E, Li G . Approved Antiviral Drugs over the Past 50 Years. Clin Microbiol Rev. 2016; 29(3):695-747. PMC: 4978613. DOI: 10.1128/CMR.00102-15. View

Sheahan T, Sims A, Graham R, Menachery V, Gralinski L, Case J . Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017; 9(396). PMC: 5567817. DOI: 10.1126/scitranslmed.aal3653. View

Riemer F, Kuehner K, Ritz S, Sauter-Louis C, Hartmann K . Clinical and laboratory features of cats with feline infectious peritonitis--a retrospective study of 231 confirmed cases (2000-2010). J Feline Med Surg. 2015; 18(4):348-56. PMC: 11112253. DOI: 10.1177/1098612X15586209. View

Agostini M, Andres E, Sims A, Graham R, Sheahan T, Lu X . Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio. 2018; 9(2). PMC: 5844999. DOI: 10.1128/mBio.00221-18. View

Hartmann K . Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?. J Feline Med Surg. 2015; 17(11):925-39. PMC: 10816252. DOI: 10.1177/1098612X15610676. View

Thomasy S, Shull O, Outerbridge C, Lim C, Freeman K, Strom A . Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006-2013). J Am Vet Med Assoc. 2016; 249(5):526-38. DOI: 10.2460/javma.249.5.526. View

10.

Takano T, Endoh M, Fukatsu H, Sakurada H, Doki T, Hohdatsu T . The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection. Antiviral Res. 2017; 145:96-102. PMC: 7113792. DOI: 10.1016/j.antiviral.2017.07.022. View

11.

Pedersen N, Liu H, Gandolfi B, Lyons L . The influence of age and genetics on natural resistance to experimentally induced feline infectious peritonitis. Vet Immunol Immunopathol. 2014; 162(1-2):33-40. PMC: 7112829. DOI: 10.1016/j.vetimm.2014.09.001. View

12.

Pedersen N, Elliott J, Glasgow A, Poland A, Keel K . An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus. Vet Microbiol. 2000; 73(4):281-300. PMC: 7117377. DOI: 10.1016/s0378-1135(00)00183-8. View

13.

Payne J, Brodbelt D, Luis Fuentes V . Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). J Vet Cardiol. 2016; 17 Suppl 1:S244-57. DOI: 10.1016/j.jvc.2015.03.008. View

14.

Murphy B, Perron M, Murakami E, Bauer K, Park Y, Eckstrand C . The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol. 2018; 219:226-233. PMC: 7117434. DOI: 10.1016/j.vetmic.2018.04.026. View

15.

Jain N, Reddy D, Verma S, Khanna R, Vaish A, Usman K . Cardiac abnormalities in HIV-positive patients: results from an observational study in India. J Int Assoc Provid AIDS Care. 2012; 13(1):40-6. DOI: 10.1177/1545109712456740. View

16.

Pedersen N, Kim Y, Liu H, Galasiti Kankanamalage A, Eckstrand C, Groutas W . Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J Feline Med Surg. 2017; 20(4):378-392. PMC: 5871025. DOI: 10.1177/1098612X17729626. View

17.

Kurnick J, WARD H, PICKETT J . Mechanism of the anemia of chronic disorders: correlation of heamtocrit value with albumin, vitamin B 12 , transferrin, and iron stores. Arch Intern Med. 1972; 130(3):323-6. DOI: 10.1001/archinte.130.3.323. View

18.

Gut M, Leutenegger C, Huder J, Pedersen N, Lutz H . One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses. J Virol Methods. 1999; 77(1):37-46. PMC: 7185542. DOI: 10.1016/s0166-0934(98)00129-3. View

19.

Weiss G, Goodnough L . Anemia of chronic disease. N Engl J Med. 2005; 352(10):1011-23. DOI: 10.1056/NEJMra041809. View

20.

Hirschberger J, Hartmann K, Wilhelm N, Frost J, Lutz H, KRAFT W . [Clinical symptoms and diagnosis of feline infectious peritonitis]. Tierarztl Prax. 1995; 23(1):92-9. View